The next phase of pre-exposure prophylaxis against SARS-CoV-2 currently rests on the shoulders of a single monoclonal ...

In the COVID-19 pandemic era, at-home, portable tests were crucial for knowing when to wear a mask or isolate at home. Now, ...

Vaccination prior to COVID-19 infection does not significantly affect neurologic symptoms in patients with long COVID.

In their Article, the HDR UK COALESCE Consortium concluded that those who are fully vaccinated against SARS-CoV-2 are less likely to be admitted to hospital and to die with COVID-19.1 If the tests for ...

A new experimental vaccine could offer protection not only against many variants of SARS-CoV-2, but also other sarbecoviruses that could spill over from animals to humans.

Traditional vaccines typically focus on the most accessible parts of viruses, which are often the rapidly mutating ...

New research emphasizes the need for ongoing COVID-19 protection for people with weakened immune systems, with scalable tests ...

Moderna (MRNA) announced that it has been awarded a tender for the supply of its mRNA COVID-19 vaccine in the European Union, Norway and North ...

Long COVID remains mysterious, with health care providers unsure which symptoms can be directly attributed to a COVID-19 ...

Although coronavirus disease 2019 (COVID-19) is no longer classified as a pandemic, a significant number of infections ...

Nearly one in 20 people who had a SARS-CoV-2 infection go on to experience myalgic encephalomyelitis/chronic fatigue syndrome ...